Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for the treatment of advanced intrahepatic cholangiocarcinoma

Figures & data

Table 1 Patient and tumor characteristics

Characteristics	Number of patients, n (%)
Age (years)
Mean	57.9
Range	43–75
Sex
Male	15 (57.7)
Female	11 (42.3)
ECOG performance status
0	8 (30.8)
1	16 (61.5)
2	2 (7.7)
Child-Pugh classification
A	10 (38.5)
B	16 (61.5)
Number of tumors
1	21 (80.8)
>1	5 (19.2)
Previous treatment
None	20 (76.9)
Recurrence after liver resection	6 (23.1)
Median CA 19-9 level, U/mL (range)	621.3 (37–4,152.5)

Abbreviations: ECOG, Eastern Cooperative Oncology Group; CA, cancer antigen.

Figure 1 A 63-year-old woman with advanced ICC treated with MWA combined with simultaneous TACE.

Notes: (A) A 63-year-old woman with a large cholangiocarcinoma (maximum diameter, 6.4 cm) in the right lobe of the liver. (B) DSA before ultrasound-guided percutaneous MWA combined with simultaneous TACE demonstrated clear hypervascularity of the lesion. (C) DSA after the procedure showed that the lesion was almost eliminated. (D) Enhanced magnetic resonance scan 1 month after the treatment showed extensive tumor necrosis in the location of the original tumor.
Abbreviations: DSA, digital subtraction angiography; MWA, microwave ablation; TACE, transarterial chemoembolization.

Figure 2 The survival curve of 26 patients with ICCs after MWA combined with simultaneous TACE treatment.

Abbreviations: ICCs, intrahepatic cholangiocarcinomas; MWA, microwave ablation; TACE, transarterial chemoembolization.